Tolar MX Eye Drop is a pain-relieving medicine. It is used after eye surgery to treat pain and inflammation. It may also be used for other conditions such as seasonal allergies. This medicine is used generally for short-term treatment only.
Tolar MX Eye Drop should be used in the dose and duration as advised by your doctor. Wash your hands thoroughly with soap and water to avoid contamination. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. The dropper tip should not come in direct contact with the affected area as there are chances of infection. Wipe off extra liquid.
Common side effects of Tolar MX Eye Drop include increase occular pressure and blurred vision. Let your doctor know if you experience any symptoms that bother you or worsen while using the medication. They may be able to suggest ways to treat or manage the side effects.
Avoid using this Tolar MX Eye Drop if you are allergic to any of its components. Use caution in case of eye injuries or infections. Consult your doctor if you experience persistent redness, pain, or worsening symptoms.
Pain is an unpleasant sensation that can result from injury, surgery, or inflammation. Tolar MX Eye Drop helps reduce pain and swelling in the eye by blocking substances in the body that cause inflammation. This provides effective relief from moderate to severe pain, improving comfort and supporting faster recovery.
How to use Tolar MX Eye Drop
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
How Tolar MX Eye Drop works
Tolar MX Eye Drop is a non-steroidal anti-inflammatory drug (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Safety advice
Alcohol
No interaction found/established
Pregnancy
SAFE IF PRESCRIBED
Tolar MX Eye Drop is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
Breast feeding
CAUTION
Tolar MX Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
Driving
UNSAFE
Tolar MX Eye Drop may cause temporary visual disturbances. Do not drive until your vision is clear.
Kidney
No interaction found/established
Liver
No interaction found/established
What if you forget to take Tolar MX Eye Drop?
If you miss a dose of Tolar MX Eye Drop, skip it and continue with your normal schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
I am suffering from chikungunya since last 2 days I m experiencing high fever and too much pain in my body Plzz suggest me about HOW TO NEUTRALIZE THE PAIN IN THE BODY
I am having pain in the joint of little finger of right hand and first finger of left hand from few hours,it occured yesterday also,plz help,i have enzomac plus and P650 at home right now
No, Tolar MX Eye Drop is neither an antibiotic nor a steroid. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines. It is used to relieve moderate to severe pain and inflammation.
Is Tolar MX Eye Drop a good painkiller?
Tolar MX Eye Drop is effective in relieving pain and inflammation. It is used to provide relief from various sorts of pain, such as sprains, strains and other injuries. It is also helpful in the treatment of different types of arthritis and gout. Along with that, it can be used to reduce pain and inflammation which follows after a surgery.
Is Tolar MX Eye Drop safe?
Tolar MX Eye Drop is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
What should I do if I forget to take a dose of Tolar MX Eye Drop?
If you forget a dose of Tolar MX Eye Drop, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take the next scheduled dose in the prescribed time. Do not double the dose to make up for the missed one as this may increase the chances of developing side effects.
Is Tolar MX Eye Drop effective?
Tolar MX Eye Drop is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Tolar MX Eye Drop too early, the symptoms may return or worsen.
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 628.
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 986.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 760-62.